| Investment [Table Text Block] |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Investments — 189.2% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — 181.9% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — Life Science — 97.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | $ | 10,000 | | | $ | 9,955 | | | $ | 9,955 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,500 | | | | 5,475 | | | | 5,475 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 11.47 | % | Prime | | | 4.72 | % | | | 9.75 | % | | | — | | | | 5.00 | % | May 1, 2026 | | | 417 | | | | 416 | | | | 416 | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,000 | | | | 3,988 | | | | 3,988 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,000 | | | | 3,988 | | | | 3,988 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,000 | | | | 3,988 | | | | 3,988 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,000 | | | | 3,988 | | | | 3,988 | |
| Long Grove Pharmaceuticals, LLC (2)(12) | | Biotechnology | | Term Loan | | | 7.67 | %(11) | 1-month
SOFR | | | 4.00 | % | | | 6.00 | % | | | — | | | | — | | February 27, 2031 | | | 10,375 | | | | 10,168 | | | | 10,168 | |
| Pelthos Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.50 | % | | | — | | | | 5.00 | % | January 31, 2031 | | | 10,000 | | | | 9,785 | | | | 9,785 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.50 | % | | | — | | | | 5.00 | % | January 31, 2031 | | | 10,000 | | | | 9,785 | | | | 9,785 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.50 | % | | | — | | | | 5.00 | % | January 31, 2031 | | | 5,000 | | | | 4,893 | | | | 4,893 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.50 | % | | | — | | | | 5.00 | % | January 31, 2031 | | | 5,000 | | | | 4,893 | | | | 4,893 | |
| Provivi, Inc. (2)(12)(13) | | Biotechnology | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | January 1, 2027 | | | 1,822 | | | | 1,561 | | | | 886 | |
| | | | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | January 1, 2027 | | | 1,822 | | | | 1,561 | | | | 886 | |
| | | | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 911 | | | | 778 | | | | 442 | |
| | | | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 911 | | | | 777 | | | | 442 | |
| | | | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 911 | | | | 777 | | | | 441 | |
| | | | | Term Loan | | | 12.11 | % | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 911 | | | | 777 | | | | 441 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Avive Solutions, Inc. (2)(12) | | Medical Device | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 5,000 | | | | 4,929 | | | | 4,929 | |
| | | | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 5,000 | | | | 4,929 | | | | 4,929 | |
| | | | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 2,500 | | | | 2,464 | | | | 2,464 | |
| | | | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 2,500 | | | | 2,464 | | | | 2,464 | |
| | | | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 2,500 | | | | 2,464 | | | | 2,464 | |
| | | | | Term Loan | | | 9.75 | % | Prime | | | 3.00 | % | | | 9.50 | % | | | — | | | | 3.00 | % | April 1, 2031 | | | 2,500 | | | | 2,464 | | | | 2,464 | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 5,000 | | | | 4,837 | | | | 4,837 | |
| | | | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 5,000 | | | | 4,957 | | | | 4,957 | |
| | | | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 4,000 | | | | 3,966 | | | | 3,966 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Term Loan | | | 13.07 | % | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | July 1, 2026 | | | 2,801 | | | | 2,793 | | | | 2,793 | |
| | | | | Term Loan | | | 13.07 | % | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | July 1, 2026 | | | 2,801 | | | | 2,793 | | | | 2,793 | |
| Hyperfine, Inc. (2)(5)(12) | | Medical Device | | Term Loan | | | 11.00 | % | Prime | | | 4.25 | % | | | 10.75 | % | | | — | | | | 5.00 | % | March 18, 2031 | | | 5,000 | | | | 4,611 | | | | 4,611 | |
| | | | | Term Loan | | | 11.00 | % | Prime | | | 4.25 | % | | | 10.75 | % | | | — | | | | 5.00 | % | March 18, 2031 | | | 5,000 | | | | 4,909 | | | | 4,909 | |
| | | | | Term Loan | | | 11.00 | % | Prime | | | 4.25 | % | | | 10.75 | % | | | — | | | | 5.00 | % | March 18, 2031 | | | 5,000 | | | | 4,909 | | | | 4,909 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | September 1, 2029 | | | 2,500 | | | | 2,384 | | | | 2,384 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | September 1, 2029 | | | 2,500 | | | | 2,434 | | | | 2,434 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | January 1, 2029 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | January 1, 2029 | | | 3,750 | | | | 3,714 | | | | 3,714 | |
| MML US, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 2,584 | | | | 2,464 | | | | 2,464 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 2,584 | | | | 2,564 | | | | 2,564 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,168 | | | | 5,127 | | | | 5,127 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,168 | | | | 5,127 | | | | 5,127 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,129 | | | | 5,087 | | | | 5,087 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,129 | | | | 5,087 | | | | 5,087 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 10,000 | | | | 9,882 | | | | 9,882 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 10,000 | | | | 9,882 | | | | 9,882 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 5,000 | | | | 4,941 | | | | 4,941 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | October 1, 2030 | | | 5,000 | | | | 4,930 | | | | 4,930 | |
| Ossio, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.25 | % | | | 3.25 | % | | | — | | | | 3.00 | % | January 20, 2031 | | | 12,549 | | | | 12,365 | | | | 12,365 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.25 | % | | | 3.25 | % | | | — | | | | 3.00 | % | January 20, 2031 | | | 7,530 | | | | 7,420 | | | | 7,420 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.25 | % | | | 3.25 | % | | | — | | | | 3.00 | % | January 20, 2031 | | | 2,501 | | | | 2,463 | | | | 2,463 | |
| Scientia Vascular, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 10,000 | | | | 9,895 | | | | 9,895 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 10,000 | | | | 9,895 | | | | 9,895 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 5,000 | | | | 4,948 | | | | 4,948 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 1,500 | | | | 1,484 | | | | 1,484 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 3,500 | | | | 3,460 | | | | 3,460 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 10,000 | | | | 9,749 | | | | 9,749 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 10,000 | | | | 9,849 | | | | 9,849 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 3,750 | | | | 3,693 | | | | 3,693 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 3,750 | | | | 3,693 | | | | 3,693 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 2,500 | | | | 2,462 | | | | 2,462 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 2,500 | | | | 2,462 | | | | 2,462 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Spineology, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 5,000 | | | | 4,942 | | | | 4,942 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 4,250 | | | | 4,200 | | | | 4,200 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 4,250 | | | | 4,200 | | | | 4,200 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 2,500 | | | | 2,471 | | | | 2,471 | |
| Total Non-Affiliate Debt Investments — Life Science | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 327,748 | | | | 325,055 | |
| Non-Affiliate Debt Investments — Sustainability — 1.5% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | May 1, 2029 | | | 2,500 | | | | 2,401 | | | | 2,401 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | May 1, 2029 | | | 2,500 | | | | 2,473 | | | | 2,473 | |
| Total Non-Affiliate Debt Investments — Sustainability | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,874 | | | | 4,874 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Technology — 59.7% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 16.79 | % | March 1, 2027 | | | 1,111 | | | | 1,016 | | | | 1,016 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 16.79 | % | March 1, 2027 | | | 1,667 | | | | 1,533 | | | | 1,533 | |
| | | | | Term Loan (17) | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 12.56 | % | February 1, 2028 | | | 3,375 | | | | 1,915 | | | | 3,374 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 12.56 | % | February 1, 2028 | | | 2,813 | | | | 2,809 | | | | 2,809 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 12.56 | % | February 1, 2028 | | | 2,813 | | | | 2,809 | | | | 2,809 | |
| Lyrical Foods, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | July 1, 2028 | | | 2,679 | | | | 2,771 | | | | 2,441 | |
| | | | | Term Loan (17) | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | July 1, 2028 | | | 2,679 | | | | 1,286 | | | | 2,361 | |
| Apkudo, Inc. (2)(12) | | Software | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 11.25 | % | | | — | | | | 3.00 | % | October 1, 2029 | | | 5,000 | | | | 4,914 | | | | 4,914 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 11.25 | % | | | — | | | | 3.00 | % | October 1, 2029 | | | 5,000 | | | | 4,914 | | | | 4,914 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.25 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 10,000 | | | | 9,837 | | | | 9,837 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.25 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 7,500 | | | | 7,415 | | | | 7,415 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 10.25 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 2,500 | | | | 2,472 | | | | 2,472 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,919 | | | | 4,919 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,938 | | | | 4,938 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,938 | | | | 4,938 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 2,000 | | | | 1,972 | | | | 1,972 | |
| Dropoff, Inc. (2)(12) | | Software | | Term Loan (17) | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 7,850 | | | | 2,450 | | | | 4,421 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 6,804 | | | | 6,795 | | | | 3,826 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 6,280 | | | | 6,272 | | | | 3,531 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 2,617 | | | | 2,616 | | | | 1,473 | |
| HappyCo, Inc. (2)(12) | | Software | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 3,000 | | | | 2,972 | | | | 2,972 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 3,000 | | | | 2,972 | | | | 2,972 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 2,000 | | | | 1,980 | | | | 1,980 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 2,000 | | | | 1,977 | | | | 1,977 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Kodiak Robotics, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 10.00 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 15,000 | | | | 14,625 | | | | 14,625 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 10.00 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 7,500 | | | | 7,312 | | | | 7,312 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 10.00 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 7,500 | | | | 7,312 | | | | 7,312 | |
| MasteryPrep, LLC (2)(12) | | Software | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | July 1, 2029 | | | 7,500 | | | | 7,387 | | | | 7,387 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | July 1, 2029 | | | 7,500 | | | | 7,437 | | | | 7,437 | |
| Mirantis, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,306 | | | | 4,270 | | | | 4,270 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,306 | | | | 4,270 | | | | 4,270 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,306 | | | | 4,270 | | | | 4,270 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,306 | | | | 4,270 | | | | 4,270 | |
| Samba TV, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | %(11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 10,039 | | | | 9,823 | | | | 9,823 | |
| | | | | Term Loan | | | 10.25 | %(11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 7,529 | | | | 7,424 | | | | 7,424 | |
| | | | | Term Loan | | | 10.25 | %(11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 5,019 | | | | 4,949 | | | | 4,949 | |
| | | | | Term Loan | | | 10.25 | %(11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 2,510 | | | | 2,475 | | | | 2,475 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,496 | | | | 2,254 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 3,500 | | | | 3,495 | | | | 3,156 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,496 | | | | 2,254 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 1,500 | | | | 1,498 | | | | 1,353 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | July 1, 2029 | | | 5,000 | | | | 4,988 | | | | 4,505 | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,348 | | | | 2,314 | | | | 2,314 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,348 | | | | 2,314 | | | | 2,314 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,348 | | | | 2,301 | | | | 2,301 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,348 | | | | 2,301 | | | | 2,301 | |
| Viken Detection Corporation (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 2,500 | | | | 2,487 | | | | 2,487 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 1,250 | | | | 1,244 | | | | 1,244 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 1,250 | | | | 1,244 | | | | 1,244 | |
| Total Non-Affiliate Debt Investments — Technology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 203,494 | | | | 199,365 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Healthcare information and services — 23.4% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| BrightInsight, Inc. (2)(12) | | Software | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 5,500 | | | | 2,905 | | | | 4,400 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 6,417 | | | | 6,403 | | | | 5,123 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 3,208 | | | | 3,202 | | | | 2,561 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 3,208 | | | | 3,202 | | | | 2,561 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 2,750 | | | | 2,734 | | | | 2,188 | |
| | | | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 2,250 | | | | 1,277 | | | | 1,800 | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 10,000 | | | | 9,948 | | | | 9,948 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,657 | | | | 3,657 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,707 | | | | 3,707 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 7,500 | | | | 7,414 | | | | 7,414 | |
| Hometeam Technologies, Inc. (2)(12)(13) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,958 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,958 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,731 | | | | 3,917 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,958 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,958 | |
| Total Non-Affiliate Debt Investments — Healthcare information and services | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 83,226 | | | | 78,030 | |
| Total Non- Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 619,342 | | | $ | 607,324 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Affiliate Warrant Investments — 5.0% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Warrants — Life Science — 2.1% (8) | | | | | | | | | | | | | | | | |
| Avalo Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 149 | | | $ | 311 | | | $ | — | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock Warrant | | | 400,000 | | | | 5 | | | | — | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 13,821 | | | | 372 | | | | 177 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 110,402 | | | | 176 | | | | 410 | |
| Imunon, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 19,671 | | | | 65 | | | | — | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 134,614 | | | | 138 | | | | 74 | |
| Mustang Bio, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 568 | | | | 146 | | | | — | |
| Native Microbials, Inc (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 178,631 | | | | 93 | | | | 4 | |
| PDS Biotechnology Corporation (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 381,625 | | | | 161 | | | | — | |
| Pelthos Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 65,488 | | | | 369 | | | | 201 | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 175,098 | | | | 278 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 709,980 | | | | 312 | | | | — | |
| Stealth Biotherapeutics Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 454,544 | | | | 266 | | | | 6 | |
| Xeris Pharmaceuticals, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 126,000 | | | | 73 | | | | 434 | |
| Aerin Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 1,818,183 | | | | 66 | | | | 1,335 | |
| Avive Solutions, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 1,434,720 | | | | 86 | | | | 86 | |
| Canary Medical Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 12,153 | | | | 86 | | | | — | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 89,903 | | | | 147 | | | | 892 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 61,170 | | | | — | | | | 4 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 7,152,669 | | | | 162 | | | | 2 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 13,203,395 | | | | 268 | | | | — | |
| CSA Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 4,939,813 | | | | 174 | | | | 468 | |
| CVRx, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 47,410 | | | | 76 | | | | 62 | |
| Hyperfine, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 562,500 | | | | 173 | | | | 102 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 8,488,456 | | | | 361 | | | | 709 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Magnolia Medical Technologies, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 900,043 | | | | 194 | | | | 325 | |
| Meditrina, Inc. (12) | | Medical Device | | Preferred Stock Warrant | | | 233,993 | | | | 83 | | | | 96 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 103,172 | | | | 47 | | | | 89 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 443,674 | | | | 192 | | | | 203 | |
| Ossio, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 34,066 | | | | 116 | | | | 116 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Common Stock Warrant | | | 24,000 | | | | 60 | | | | 101 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 49,157 | | | | 206 | | | | 734 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 5,592,571 | | | | 443 | | | | 197 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 27,139 | | | | 65 | | | | 1 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 45,101 | | | | 109 | | | | 16 | |
| VERO Biotech LLC (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 3,701 | | | | 379 | | | | 113 | |
| Total Non-Affiliate Warrants — Life Science | | | | | | | 6,258 | | | | 6,957 | |
| Non-Affiliate Warrants — Sustainability — 0.0% (8) | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Preferred Stock Warrant | | | 2,264,151 | | | | 45 | | | | 37 | |
| Pivot Bio, Inc. (2)(12) | | Energy Efficiency | | Preferred Stock Warrant | | | 210,418 | | | | 14 | | | | 2 | |
| LiquiGlide, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 122,717 | | | | 53 | | | | 47 | |
| Temperpack Technologies, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 66,605 | | | | 185 | | | | 28 | |
| Total Non-Affiliate Warrants — Sustainability | | | | | | | 297 | | | | 114 | |
| Non-Affiliate Warrants — Technology — 2.8% (8) | | | | | | | | | | | | |
| Axiom Space Holdings, Inc. (2)(12) | | Communications | | Common Stock Warrant | | | 2,654 | | | | 50 | | | | 38 | |
| Intelepeer Holdings, Inc. (2)(12) | | Communications | | Preferred Stock Warrant | | | 2,936,535 | | | | 138 | | | | 2,737 | |
| Alula Holdings, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 20,000 | | | | 93 | | | | 7 | |
| CAMP NYC, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 224,712 | | | | 57 | | | | 77 | |
| Clara Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 46,745 | | | | 30 | | | | 42 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 13,068 | | | | 80 | | | | 59 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 71,014 | | | | 538 | | | | 771 | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 1,633,929 | | | | 3,463 | | | | 3,510 | |
| MyForest Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 500 | | | | 41 | | | | 48 | |
| Primary Kids, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 553,778 | | | | 57 | | | | 65 | |
| Quip NYC Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 10,833 | | | | 325 | | | | — | |
| Updater, Inc.(2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 108,333 | | | | 34 | | | | — | |
| CPG Beyond, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 500,000 | | | | 242 | | | | 44 | |
| Silk, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 394,110 | | | | 175 | | | | 177 | |
| Global Worldwide LLC (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 245,810 | | | | 75 | | | | — | |
| Rocket Lawyer Incorporated (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 261,721 | | | | 92 | | | | 67 | |
| Skillshare, Inc. (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 139,316 | | | | 162 | | | | — | |
| Liqid, Inc. (2)(12) | | Networking | | Common Stock Warrant | | | 344,102 | | | | 364 | | | | — | |
| Apkudo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 31,848 | | | | 97 | | | | 46 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 194,570 | | | | 137 | | | | 451 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 260,972 | | | | 138 | | | | 178 | |
| Dropoff, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 723,228 | | | | 455 | | | | — | |
| HappyCo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 96,228 | | | | 26 | | | | 20 | |
| Everstream Holdings, LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 525,000 | | | | 82 | | | | — | |
| Lemongrass Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 202,616 | | | | 57 | | | | 87 | |
| Mirantis, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 948,275 | | | | 223 | | | | 425 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Noodle Partners, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 84,037 | | | | 116 | | | | — | |
| OneNetworks, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 184,646 | | | | 3 | | | | 2 | |
| Revinate Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 682,034 | | | | 44 | | | | 86 | |
| SIGNiX, Inc. (12) | | Software | | Preferred Stock Warrant | | | 186,235 | | | | 177 | | | | — | |
| Slingshot Aerospace, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 309,208 | | | | 123 | | | | 45 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 682 | | | | 64 | | | | — | |
| Topia Mobility, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 30,496 | | | | 138 | | | | — | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 1,075,072 | | | | 151 | | | | 144 | |
| Viken Detection Corporation (2)(12) | | Software | | Preferred Stock Warrant | | | 345,443 | | | | 120 | | | | 316 | |
| Total Non-Affiliate Warrants — Technology | | | | | | | 8,167 | | | | 9,442 | |
| Non-Affiliate Warrants — Healthcare information and services — 0.1% (8) | | | | | | | | | | | | | | | | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare | | Preferred Stock Warrant | | | 326,640 | | | | 144 | | | | 72 | |
| BrightInsight, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 232,871 | | | | 168 | | | | — | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 652,250 | | | | 191 | | | | — | |
| SafelyYou, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 206,983 | | | | 163 | | | | 100 | |
| Total Non-Affiliate Warrants — Healthcare information and services | | | | | | | 666 | | | | 172 | |
| Total Non-Affiliate Warrants | | | | | | $ | 15,388 | | | $ | 16,685 | |
| Non-Affiliate Other Investments — 0.7% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Other Investments — Life Science — 0.7% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Royalty Agreement | | | | | | $ | 5,073 | | | $ | — | |
| Aerobiotix, LLC (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,372 | | | | 1,827 | |
| Lumithera, Inc. (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,083 | | | | 351 | |
| Robin Healthcare, Inc. (2)(12) | | Medical Device | | Royalty Agreement | | | | | | | 7,330 | | | | — | |
| Total Non-Affiliate Other Investments — Life Science | | | | | | | 14,858 | | | | 2,178 | |
| Non-Affiliate Other Investments — Technology — 0.0% (8) | | | | | | | | | | | | | | | | |
| Better Place Forests Co. (12)(16) | | Consumer-related Technologies | | Other Investment | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments — Technology | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments | | | | | | $ | 25,007 | | | $ | 2,178 | |
| Non-Affiliate Equity — 1.6% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock | | | 66,170 | | | $ | 14 | | | $ | 5 | |
| Cadrenal Therapeutics, Inc. (5) | | Biotechnology | | Common Stock | | | 40,000 | | | | — | | | | 204 | |
| Castle Creek Biosciences, Inc. (12) | | Biotechnology | | Common Stock | | | 1,162 | | | | 250 | | | | 217 | |
| Emalex Biosciences, Inc. (12) | | Biotechnology | | Preferred Stock | | | 47,461 | | | | 545 | | | | 656 | |
| Axiom Space Holdings, Inc. (12) | | Communications | | Preferred Stock | | | 1,810 | | | | 261 | | | | 306 | |
| PebblePost, Inc. (2)(12) | | Communications | | Preferred Stock | | | 56,212 | | | | 73 | | | | 73 | |
| SnagAJob.com, Inc. (12) | | Consumer-related Technologies | | Common Stock | | | 82,974 | | | | 9 | | | | — | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock | | | 16,247,754 | | | | 976 | | | | 975 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock | | | 2,119,272 | | | | 500 | | | | 500 | |
| Tigo Energy, Inc. (5) | | Other Sustainability | | Common Stock | | | 5,205 | | | | 111 | | | | 21 | |
| Decisyon, Inc. (12) | | Software | | Preferred Stock | | | 280,000 | | | | 2,800 | | | | — | |
| Kodiak Robotics, Inc. (2)(5) | | Software | | Common Stock | | | 338,798 | | | | 3,100 | | | | 2,351 | |
| Total Non-Affiliate Equity | | | | | | $ | 8,639 | | | $ | 5,308 | |
| Total Non-Affiliate Portfolio Investment Assets | | | | | | $ | 668,376 | | | $ | 631,495 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Controlled Affiliate Investments — 19.2% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Controlled Affiliate Debt Investments — 11.5% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Hound Labs II, LLC (12) | | Diagnostics | | Term Loan | | | 12.75 | % (11) | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | — | | July 1, 2027 | | $ | 7,008 | | | $ | 7,008 | | | $ | 6,809 | |
| NextCar Holding Company, Inc. (12)(14) | | Consumer-related Technologies | | Term Loan | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | March 31, 2026 | | | 2,024 | | | | 2,024 | | | | 1,005 | |
| Nexii, Inc. (12) | | Other Sustainability | | Term Loan | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 790 | | | | 830 | | | | — | |
| | | | | Term Loan (17) | | | 10.00 | % | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 304 | | | | 172 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Term Loan (17) | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 5,402 | | | | 583 | | | | 5,402 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,601 | | | | 3,557 | | | | 3,557 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,801 | | | | 1,778 | | | | 1,778 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,601 | | | | 3,556 | | | | 3,556 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,801 | | | | 1,778 | | | | 1,778 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,601 | | | | 3,554 | | | | 3,554 | |
| | | | | Term Loan | | | 11.75 | % (11) | Prime | | | 5.00 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,801 | | | | 1,777 | | | | 1,777 | |
| | | | | Revolver | | | 11.75 | % | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 5,000 | | | | 5,000 | |
| | | | | Revolver | | | 11.75 | % | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 4,089 | | | | 4,089 | |
| Total Non-Controlled Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 35,706 | | | | 38,305 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Controlled Affiliate Other Investments — 0.4% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12)(15) | | Biotechnology | | Other Investment | | | | | | | 20,092 | | | | 1,486 | |
| Total Non-Controlled Affiliate Other Investments | | | | | | | 20,092 | | | | 1,486 | |
| Non-controlled Affiliate Equity — 7.3% (8) | | | | | | | | | | | | | | | | |
| Aulea Medical, Inc. (12) | | Medical Device | | Common Stock | | | 660,537 | | | | — | | | | — | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock | | | 2,164,502 | | | | 5,000 | | | | — | |
| Hound Labs II, LLC (12) | | Diagnostics | | Preferred Stock | | | 4,769 | | | | 4,764 | | | | 4,764 | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock | | | 2,688,971 | | | | — | | | | — | |
| Nexii, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 168,377 | | | | 9,751 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Common Stock | | | 4,274,555 | | | | 1,292 | | | | 1,292 | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 1,964,733 | | | | 13,209 | | | | 18,355 | |
| Total Non-Controlled Affiliate Equity | | | | | | | 34,016 | | | | 24,411 | |
| Non-controlled Affiliate Warrants — 0.0% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 23,196 | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Warrants | | | | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Portfolio Investment Assets | | | | | | $ | 89,941 | | | $ | 64,202 | |
| Total Portfolio Investment Assets — 208.4% (8) | | | | | | $ | 758,317 | | | $ | 695,697 | |
| Short Term Investments - Unrestricted Investments - 10.8% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 36,139 | | | | 36,139 | |
| Total Short Term Investments - Unrestricted Investments | | $ | 36,139 | | | $ | 36,139 | |
| | | | | | | | | |
| Short Term Investments - Restricted Investments - 0.8% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 2,634 | | | | 2,634 | |
| Total Short Term Investments - Restricted Investments | | $ | 2,634 | | | $ | 2,634 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Investments — 183.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — 175.4% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Affiliate Debt Investments — Life Science — 85.2% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | $ | 10,000 | | | $ | 9,947 | | | $ | 9,947 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,500 | | | | 5,471 | | | | 5,471 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 4.00 | % | March 1, 2028 | | | 5,000 | | | | 4,974 | | | | 4,974 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 11.47 | % | Prime | | | 4.72 | % | | | 9.75 | % | | | — | | | | 5.00 | % | May 1, 2026 | | | 1,667 | | | | 1,665 | | | | 1,665 | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.75 | % | | | 10.75 | % | | | — | | | | 5.00 | % | April 1, 2030 | | | 4,250 | | | | 4,237 | | | | 4,237 | |
| Long Grove Pharmaceuticals, LLC (2)(12) | | Biotechnology | | Term Loan | | | 7.87% | (11) | 1-month
SOFR | | | 4.00 | % | | | 6.00 | % | | | — | | | | — | | February 27, 2031 | | | 10,298 | | | | 10,086 | | | | 10,086 | |
| Provivi, Inc. (2)(12)(13) | | Biotechnology | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | January 1, 2027 | | | 1,906 | | | | 1,683 | | | | 924 | |
| | | | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.30 | % | January 1, 2027 | | | 1,906 | | | | 1,683 | | | | 924 | |
| | | | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| | | | | Term Loan | | | 12.11% | (11) | Prime | | | 5.36 | % | | | 9.50 | % | | | — | | | | 4.31 | % | January 1, 2027 | | | 953 | | | | 838 | | | | 460 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 5,000 | | | | 4,833 | | | | 4,833 | |
| | | | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 5,000 | | | | 4,954 | | | | 4,954 | |
| | | | | Term Loan | | | 9.50 | % | Prime | | | 2.75 | % | | | 9.25 | % | | | — | | | | 4.00 | % | March 1, 2029 | | | 4,000 | | | | 3,963 | | | | 3,963 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Term Loan | | | 13.07 | % | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | July 1, 2026 | | | 2,801 | | | | 2,785 | | | | 2,785 | |
| | | | | Term Loan | | | 13.07 | % | Prime | | | 6.32 | % | | | 10.75 | % | | | — | | | | 10.88 | % | July 1, 2026 | | | 2,801 | | | | 2,785 | | | | 2,785 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 2.00 | % | September 1, 2029 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | September 1, 2029 | | | 2,500 | | | | 2,379 | | | | 2,379 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 4.00 | % | September 1, 2029 | | | 2,500 | | | | 2,429 | | | | 2,429 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | January 1, 2029 | | | 3,750 | | | | 3,710 | | | | 3,710 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 3.50 | % | January 1, 2029 | | | 3,750 | | | | 3,710 | | | | 3,710 | |
| MML US, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 2,565 | | | | 2,444 | | | | 2,444 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 2,565 | | | | 2,543 | | | | 2,543 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,129 | | | | 5,086 | | | | 5,086 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,129 | | | | 5,086 | | | | 5,086 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,091 | | | | 5,046 | | | | 5,046 | |
| | | | | Term Loan | | | 10.00 | % (11) | Prime | | | 3.00 | % | | | 10.00 | % | | | 13.50 | % | | | 3.00 | % | March 1, 2030 | | | 5,091 | | | | 5,046 | | | | 5,046 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 10,000 | | | | 9,874 | | | | 9,874 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 10,000 | | | | 9,874 | | | | 9,874 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 5,000 | | | | 4,937 | | | | 4,937 | |
| | | | | Term Loan | | | 10.75 | % | Prime | | | 3.25 | % | | | 10.75 | % | | | — | | | | 4.00 | % | October 1, 2030 | | | 5,000 | | | | 4,926 | | | | 4,926 | |
| Scientia Vascular, Inc. (2)(12) | | Medical Device | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 10,000 | | | | 9,890 | | | | 9,890 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 10,000 | | | | 9,890 | | | | 9,890 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 5,000 | | | | 4,945 | | | | 4,945 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 1,500 | | | | 1,483 | | | | 1,483 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 2.75 | % | | | 10.25 | % | | | — | | | | 4.00 | % | July 1, 2030 | | | 3,500 | | | | 3,459 | | | | 3,459 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | September 1, 2027 | | | 2,500 | | | | 2,489 | | | | 2,489 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | September 1, 2027 | | | 2,500 | | | | 2,489 | | | | 2,489 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | September 1, 2027 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | September 1, 2027 | | | 5,000 | | | | 4,977 | | | | 4,977 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 8.00 | % | April 1, 2028 | | | 3,750 | | | | 3,725 | | | | 3,725 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Spineology, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 5,000 | | | | 4,936 | | | | 4,936 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 4,250 | | | | 4,195 | | | | 4,195 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 4,250 | | | | 4,196 | | | | 4,196 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 5.00 | % | | | 12.00 | % | | | — | | | | 1.00 | % | August 1, 2029 | | | 2,500 | | | | 2,468 | | | | 2,468 | |
| Vero Biotech, Inc. (2)(12) | | Medical Device | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 15,000 | | | | 14,803 | | | | 14,803 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 10,000 | | | | 9,869 | | | | 9,869 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.25 | % | Prime | | | 3.75 | % | | | 12.25 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 2,500 | | | | 2,466 | | | | 2,466 | |
| Total Non-Affiliate Debt Investments — Life Science | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 274,306 | | | | 271,276 | |
| Non-Affiliate Debt Investments — Sustainability — 1.5% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | May 1, 2029 | | | 2,500 | | | | 2,398 | | | | 2,398 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 5.00 | % | May 1, 2029 | | | 2,500 | | | | 2,471 | | | | 2,471 | |
| Total Non-Affiliate Debt Investments — Sustainability | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 4,869 | | | | 4,869 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Technology — 63.3% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | March 1, 2027 | | | 1,111 | | | | 982 | | | | 982 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 5.00 | % | | | 5.00 | % | | | — | | | | 10.40 | % | March 1, 2027 | | | 1,667 | | | | 1,482 | | | | 1,482 | |
| | | | | Term Loan (17) | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | February 1, 2028 | | | 3,375 | | | | 1,915 | | | | 3,374 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.50 | % | | | 10.50 | % | | | — | | | | 7.78 | % | February 1, 2028 | | | 2,813 | | | | 2,813 | | | | 2,813 | |
| Lyrical Foods, Inc. (2)(12) | | Consumer-related Technologies | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | July 1, 2028 | | | 2,679 | | | | 2,771 | | | | 2,400 | |
| | | | | Term Loan (17) | | | 10.25 | % | Prime | | | 3.50 | % | | | 9.00 | % | | | — | | | | 5.00 | % | July 1, 2028 | | | 2,679 | | | | 1,286 | | | | 2,320 | |
| Apkudo, Inc. (2)(12) | | Software | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 7.00 | % | | | — | | | | 3.00 | % | October 1, 2029 | | | 5,000 | | | | 4,908 | | | | 4,908 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 4.25 | % | | | 7.00 | % | | | — | | | | 3.00 | % | October 1, 2029 | | | 5,000 | | | | 4,908 | | | | 4,908 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 10,000 | | | | 9,831 | | | | 9,831 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 7,500 | | | | 7,410 | | | | 7,410 | |
| | | | | Term Loan | | | 10.50 | % | Prime | | | 3.75 | % | | | 6.50 | % | | | — | | | | 3.00 | % | January 1, 2031 | | | 2,500 | | | | 2,470 | | | | 2,470 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,894 | | | | 4,894 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 5,000 | | | | 4,933 | | | | 4,933 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.50 | % | | | 12.00 | % | | | — | | | | 4.00 | % | January 1, 2029 | | | 2,000 | | | | 1,969 | | | | 1,969 | |
| Dropoff, Inc. (2)(12) | | Software | | Term Loan (17) | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 7,850 | | | | 2,450 | | | | 4,411 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 6,804 | | | | 6,785 | | | | 3,813 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 6,280 | | | | 6,263 | | | | 3,520 | |
| | | | | Term Loan | | | 13.25 | % | Prime | | | 6.50 | % | | | 9.75 | % | | | — | | | | 3.50 | % | June 1, 2026 | | | 2,617 | | | | 2,613 | | | | 1,468 | |
| HappyCo, Inc. (2)(12) | | Software | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 3,000 | | | | 2,969 | | | | 2,969 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 3,000 | | | | 2,969 | | | | 2,969 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 2,000 | | | | 1,978 | | | | 1,978 | |
| | | | | Term Loan | | | 11.13 | % | Prime | | | 3.75 | % | | | 11.00 | % | | | — | | | | 2.75 | % | February 1, 2030 | | | 2,000 | | | | 1,975 | | | | 1,975 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Kodiak Robotics, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 15,000 | | | | 14,599 | | | | 14,599 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 7,500 | | | | 7,300 | | | | 7,300 | |
| | | | | Term Loan | | | 10.25 | % | Prime | | | 3.50 | % | | | 6.50 | % | | | — | | | | 4.00 | % | January 1, 2030 | | | 7,500 | | | | 7,300 | | | | 7,300 | |
| MasteryPrep, LLC (2)(12) | | Software | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | July 1, 2029 | | | 7,500 | | | | 7,383 | | | | 7,383 | |
| | | | | Term Loan | | | 11.50 | % | Prime | | | 4.00 | % | | | 11.50 | % | | | — | | | | 3.75 | % | July 1, 2029 | | | 7,500 | | | | 7,433 | | | | 7,433 | |
| Mirantis, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2028 | | | 4,583 | | | | 4,541 | | | | 4,541 | |
| Samba TV, Inc. (2)(12) | | Software | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 10,014 | | | | 9,792 | | | | 9,792 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 7,510 | | | | 7,400 | | | | 7,400 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 5,007 | | | | 4,934 | | | | 4,934 | |
| | | | | Term Loan | | | 10.25 | % (11) | Prime | | | 3.50 | % | | | 3.50 | % | | | — | | | | 4.00 | % | December 1, 2030 | | | 2,503 | | | | 2,467 | | | | 2,467 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,435 | | | | 2,280 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 3,500 | | | | 3,495 | | | | 3,273 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 2,500 | | | | 2,496 | | | | 2,338 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | June 1, 2028 | | | 1,500 | | | | 1,498 | | | | 1,403 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.25 | % | | | 12.00 | % | | | — | | | | 2.50 | % | July 1, 2029 | | | 5,000 | | | | 4,988 | | | | 4,671 | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,460 | | | | 2,460 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,460 | | | | 2,460 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,445 | | | | 2,445 | |
| | | | | Term Loan | | | 12.00 | % | Prime | | | 4.00 | % | | | 12.00 | % | | | — | | | | 3.00 | % | November 1, 2028 | | | 2,500 | | | | 2,445 | | | | 2,445 | |
| Viken Detection Corporation (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 2,833 | | | | 2,814 | | | | 2,814 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 1,417 | | | | 1,407 | | | | 1,407 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 4.00 | % | | | 11.75 | % | | | — | | | | 3.50 | % | June 1, 2027 | | | 1,417 | | | | 1,407 | | | | 1,407 | |
| Total Non-Affiliate Debt Investments — Technology | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 205,442 | | | | 201,718 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Affiliate Debt Investments — Healthcare information and services — 25.4% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| BrightInsight, Inc. (2)(12) | | Software | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 5,500 | | | | 2,905 | | | | 5,105 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 6,417 | | | | 6,398 | | | | 5,939 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 3,208 | | | | 3,199 | | | | 2,969 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 3,208 | | | | 3,199 | | | | 2,969 | |
| | | | | Term Loan | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 2,750 | | | | 2,731 | | | | 2,535 | |
| | | | | Term Loan (17) | | | 12.50 | % | Prime | | | 5.50 | % | | | 9.50 | % | | | — | | | | 4.00 | % | August 1, 2027 | | | 2,250 | | | | 1,277 | | | | 2,089 | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 10,000 | | | | 9,936 | | | | 9,936 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| | | | | Term Loan | | | 11.75 | % | Prime | | | 3.50 | % | | | 11.75 | % | | | — | | | | 4.00 | % | October 1, 2027 | | | 5,000 | | | | 4,968 | | | | 4,968 | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,604 | | | | 3,604 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 3,750 | | | | 3,705 | | | | 3,705 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 4.00 | % | October 1, 2029 | | | 7,500 | | | | 7,409 | | | | 7,409 | |
| Hometeam Technologies, Inc. (2)(12)(13) | | Other Healthcare Services | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,682 | | | | 3,883 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| | | | | Term Loan | | | 11.25 | % | Prime | | | 3.25 | % | | | 11.25 | % | | | — | | | | 3.50 | % | August 1, 2029 | | | 4,821 | | | | 4,781 | | | | 3,967 | |
| Total Non-Affiliate Debt Investments — Healthcare information and services | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 83,073 | | | | 80,915 | |
| Total Non- Affiliate Debt Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | $ | 567,690 | | | $ | 558,778 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Affiliate Warrant Investments — 5.2% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Warrants — Life Science — 2.2% (8) | | | | | | | | | | | | | | | | |
| Avalo Therapeutics, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 149 | | | $ | 311 | | | $ | — | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock Warrant | | | 400,000 | | | | 5 | | | | — | |
| Castle Creek Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 13,821 | | | | 372 | | | | 274 | |
| Emalex Biosciences, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 110,402 | | | | 176 | | | | 447 | |
| Imunon, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 19,671 | | | | 65 | | | | — | |
| KSQ Therapeutics, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 134,614 | | | | 138 | | | | 13 | |
| Mustang Bio, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 568 | | | | 146 | | | | — | |
| Native Microbials, Inc (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 178,631 | | | | 93 | | | | 4 | |
| PDS Biotechnology Corporation (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 381,625 | | | | 161 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 175,098 | | | | 278 | | | | — | |
| Provivi, Inc. (2)(12) | | Biotechnology | | Preferred Stock Warrant | | | 709,980 | | | | 312 | | | | — | |
| Stealth Biotherapeutics Inc. (2)(12) | | Biotechnology | | Common Stock Warrant | | | 454,544 | | | | 266 | | | | 6 | |
| Xeris Pharmaceuticals, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 126,000 | | | | 73 | | | | 691 | |
| Aerin Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 1,818,183 | | | | 66 | | | | 1,333 | |
| Canary Medical Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 12,153 | | | | 86 | | | | — | |
| Ceribell, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 89,903 | | | | 147 | | | | 1,205 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 61,170 | | | | — | | | | 2 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 7,152,669 | | | | 162 | | | | 3 | |
| Conventus Orthopaedics, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 13,203,395 | | | | 268 | | | | — | |
| CSA Medical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 4,939,813 | | | | 174 | | | | 462 | |
| CVRx, Inc. (2)(5)(12) | | Medical Device | | Common Stock Warrant | | | 47,410 | | | | 76 | | | | 20 | |
| Infobionic, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 8,488,456 | | | | 361 | | | | 705 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Magnolia Medical Technologies, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 900,043 | | | | 194 | | | | 321 | |
| Meditrina, Inc. (12) | | Medical Device | | Preferred Stock Warrant | | | 233,993 | | | | 83 | | | | 95 | |
| Mobia Medical, Inc. fka Microtransponder, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 103,172 | | | | 47 | | | | 47 | |
| Onkos Surgical, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 443,674 | | | | 192 | | | | 200 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Common Stock Warrant | | | 24,000 | | | | 60 | | | | 235 | |
| Scientia Vascular, Inc (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 49,157 | | | | 206 | | | | 481 | |
| Sonex Health, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 2,637,133 | | | | 275 | | | | 199 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Common Stock Warrant | | | 27,139 | | | | 65 | | | | 41 | |
| Spineology, Inc. (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 45,101 | | | | 109 | | | | 69 | |
| VERO Biotech LLC (2)(12) | | Medical Device | | Preferred Stock Warrant | | | 3,701 | | | | 379 | | | | 111 | |
| Total Non-Affiliate Warrants — Life Science | | | | | | | 5,346 | | | | 6,964 | |
| Non-Affiliate Warrants — Sustainability — 0.0% (8) | | | | | | | | | | | | | | | | |
| SparkCharge, Inc. (2)(12) | | Alternative Energy | | Preferred Stock Warrant | | | 2,264,151 | | | | 45 | | | | 36 | |
| Pivot Bio, Inc. (2)(12) | | Energy Efficiency | | Preferred Stock Warrant | | | 210,418 | | | | 14 | | | | 2 | |
| New Aerofarms, Inc. assignee of Aerofarms, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 800,000 | | | | 88 | | | | 30 | |
| LiquiGlide, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 122,717 | | | | 53 | | | | 47 | |
| Temperpack Technologies, Inc. (2)(12) | | Other Sustainability | | Preferred Stock Warrant | | | 66,605 | | | | 185 | | | | 28 | |
| Total Non-Affiliate Warrants — Sustainability | | | | | | | 385 | | | | 143 | |
| Non-Affiliate Warrants — Technology — 3.0% (8) | | | | | | | | | | | | | | | | |
| Axiom Space Holdings, Inc. (2)(12) | | Communications | | Common Stock Warrant | | | 2,654 | | | | 50 | | | | 33 | |
| Intelepeer Holdings, Inc. (2)(12) | | Communications | | Preferred Stock Warrant | | | 2,936,535 | | | | 138 | | | | 2,730 | |
| Alula Holdings, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 20,000 | | | | 93 | | | | 6 | |
| CAMP NYC, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 224,712 | | | | 57 | | | | 76 | |
| Clara Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 46,745 | | | | 30 | | | | 41 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 13,068 | | | | 80 | | | | 59 | |
| Divergent Technologies, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 71,014 | | | | 538 | | | | 771 | |
| Havenly, Inc. (2)(12) | | Consumer-related Technologies | | Common Stock Warrant | | | 1,633,929 | | | | 3,463 | | | | 3,510 | |
| MyForest Foods Co. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 500 | | | | 41 | | | | 47 | |
| Primary Kids, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 553,778 | | | | 57 | | | | 73 | |
| Quip NYC Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 10,833 | | | | 325 | | | | — | |
| Updater, Inc.(2)(12) | | Consumer-related Technologies | | Preferred Stock Warrant | | | 108,333 | | | | 34 | | | | — | |
| CPG Beyond, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 500,000 | | | | 242 | | | | 57 | |
| Silk, Inc. (2)(12) | | Data Storage | | Preferred Stock Warrant | | | 394,110 | | | | 175 | | | | 173 | |
| Global Worldwide LLC (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 245,810 | | | | 75 | | | | — | |
| Rocket Lawyer Incorporated (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 261,721 | | | | 92 | | | | 151 | |
| Skillshare, Inc. (2)(12) | | Internet and Media | | Preferred Stock Warrant | | | 139,316 | | | | 162 | | | | — | |
| Liqid, Inc. (2)(12) | | Networking | | Common Stock Warrant | | | 344,102 | | | | 364 | | | | — | |
| Apkudo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 31,848 | | | | 97 | | | | 118 | |
| BriteCore Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 194,570 | | | | 137 | | | | 229 | |
| Crafty Holdings, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 260,972 | | | | 138 | | | | 178 | |
| Dropoff, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 723,228 | | | | 455 | | | | — | |
| HappyCo, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 96,228 | | | | 26 | | | | 20 | |
| Everstream Holdings, LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 525,000 | | | | 82 | | | | — | |
| Lemongrass Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 202,616 | | | | 57 | | | | 96 | |
| Mirantis, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 948,275 | | | | 223 | | | | 420 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Noodle Partners, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 84,037 | | | | 116 | | | | — | |
| OneNetworks, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 184,646 | | | | 3 | | | | 2 | |
| Revinate Holdings, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 682,034 | | | | 44 | | | | 86 | |
| SIGNiX, Inc. (12) | | Software | | Preferred Stock Warrant | | | 186,235 | | | | 177 | | | | — | |
| Slingshot Aerospace, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 309,208 | | | | 123 | | | | 45 | |
| Supply Network Visibility Holdings LLC (2)(12) | | Software | | Preferred Stock Warrant | | | 682 | | | | 64 | | | | — | |
| Topia Mobility, Inc. (2)(12) | | Software | | Common Stock Warrant | | | 30,496 | | | | 138 | | | | — | |
| Ursa Space Systems, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 1,075,072 | | | | 151 | | | | 169 | |
| Viken Detection Corporation (2)(12) | | Software | | Preferred Stock Warrant | | | 345,443 | | | | 120 | | | | 314 | |
| xAd, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 4,343,348 | | | | 177 | | | | — | |
| Total Non-Affiliate Warrants — Technology | | | | | | | 8,344 | | | | 9,404 | |
| Non-Affiliate Warrants — Healthcare information and services — 0.0% (8) | | | | | | | | | | | | | | | | |
| GT Medical Technologies, Inc. (2)(12) | | Other Healthcare | | Preferred Stock Warrant | | | 326,640 | | | | 144 | | | | 39 | |
| BrightInsight, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 232,871 | | | | 168 | | | | — | |
| Elligo Health Research, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 652,250 | | | | 191 | | | | — | |
| SafelyYou, Inc. (2)(12) | | Software | | Preferred Stock Warrant | | | 206,983 | | | | 163 | | | | 98 | |
| Total Non-Affiliate Warrants — Healthcare information and services | | | | | | | 666 | | | | 137 | |
| Total Non-Affiliate Warrants | | | | | | | 14,741 | | | | 16,648 | |
| Non-Affiliate Other Investments — 0.6% (8) | | | | | | | | | | | | | | | | |
| Non-Affiliate Other Investments — Life Science — 0.6% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Royalty Agreement | | | | | | | 5,073 | | | | — | |
| Aerobiotix, LLC (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,498 | | | | 1,574 | |
| Lumithera, Inc. (12) | | Medical Device | | Royalty Agreement | | | | | | | 1,116 | | | | 384 | |
| Robin Healthcare, Inc. (2)(12) | | Medical Device | | Royalty Agreement | | | | | | | 7,330 | | | | — | |
| Total Non-Affiliate Other Investments — Life Science | | | | | | | 15,017 | | | | 1,958 | |
| Non-Affiliate Other Investments — Technology — 0.0% (8) | | | | | | | | | | | | | | | | |
| Better Place Forests Co. (12)(16) | | Consumer-related Technologies | | Other Investment | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments — Technology | | | | | | | 10,149 | | | | — | |
| Total Non-Affiliate Other Investments | | | | | | | 25,166 | | | | 1,958 | |
| Non-Affiliate Equity — 2.1% (8) | | | | | | | | | | | | | | | | |
| BioVaxys Technology Corp. (5)(12) | | Biotechnology | | Common Stock | | | 66,170 | | | | 14 | | | | 11 | |
| Cadrenal Therapeutics, Inc. (5) | | Biotechnology | | Common Stock | | | 40,000 | | | | — | | | | 271 | |
| Castle Creek Biosciences, Inc. (12) | | Biotechnology | | Common Stock | | | 1,162 | | | | 250 | | | | 217 | |
| Emalex Biosciences, Inc. (12) | | Biotechnology | | Preferred Stock | | | 47,461 | | | | 545 | | | | 656 | |
| Axiom Space Holdings, Inc. (12) | | Communications | | Preferred Stock | | | 1,810 | | | | 261 | | | | 306 | |
| PebblePost, Inc. (2)(12) | | Communications | | Preferred Stock | | | 56,212 | | | | 73 | | | | 73 | |
| SnagAJob.com, Inc. (12) | | Consumer-related Technologies | | Common Stock | | | 82,974 | | | | 9 | | | | — | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Common Stock | | | 16,247,754 | | | | 976 | | | | 975 | |
| Cognoa, Inc. (2)(12) | | Medical Device | | Preferred Stock | | | 2,119,272 | | | | 500 | | | | 500 | |
| Tigo Energy, Inc. (5) | | Other Sustainability | | Common Stock | | | 5,205 | | | | 111 | | | | 7 | |
| Decisyon, Inc. (12) | | Software | | Preferred Stock | | | 280,000 | | | | 2,800 | | | | — | |
| Kodiak Robotics, Inc. (2)(5) | | Software | | Common Stock | | | 338,798 | | | | 3,100 | | | | 3,700 | |
| Total Non-Affiliate Equity | | | | | | $ | 8,639 | | | $ | 6,716 | |
| Total Non-Affiliate Portfolio Investment Assets | | | | | | $ | 616,236 | | | $ | 584,100 | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Cash Rate (4) | | | Index | | Margin | | | Floor | | | Ceiling | | | ETP (10) | | Maturity Date | | Principal Amount | | | Cost of Investments (6)(9) | | | Fair Value (9) | |
| Non-Controlled Affiliate Investments — 19.9% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Non-Controlled Affiliate Debt Investments — 11.7% (8) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Hound Labs II, LLC (12) | | Diagnostics | | Term Loan | | | 12.75% | (11) | | Prime | | | 6.00 | % | | | 9.25 | % | | | — | | | | — | | July 1, 2027 | | $ | 6,789 | | | $ | 6,789 | | | $ | 6,605 | |
| NextCar Holding Company, Inc. (12)(14) | | Consumer-related Technologies | | Term Loan | | | 10.00 | % | | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | March 31, 2026 | | | 2,266 | | | | 2,266 | | | | 1,079 | |
| Nexii, Inc. (12) | | Other Sustainability | | Term Loan | | | 10.00 | % | | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 790 | | | | 826 | | | | — | |
| | | | | Term Loan (17) | | | 10.00 | % | | Fixed | | | 0.00 | % | | | 0.00 | % | | | — | | | | — | | July 1, 2027 | | | 304 | | | | 172 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Term Loan (17) | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 5,246 | | | | 428 | | | | 5,246 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,447 | | | | 3,447 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,724 | | | | 1,724 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,447 | | | | 3,447 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,723 | | | | 1,723 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 3,497 | | | | 3,445 | | | | 3,445 | |
| | | | | Term Loan | | | 11.75% | (11) | | Prime | | | 4.50 | % | | | 11.75 | % | | | — | | | | 2.75 | % | September 1, 2028 | | | 1,749 | | | | 1,722 | | | | 1,722 | |
| | | | | Revolver | | | 11.75 | % | | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 5,000 | | | | 5,000 | |
| | | | | Revolver | | | 11.75 | % | | Prime | | | 5.00 | % | | | 9.75 | % | | | — | | | | — | | November 26, 2026 | | | 5,000 | | | | 3,809 | | | | 3,809 | |
| Total Non-Controlled Affiliate Investments | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 34,798 | | | | 37,247 | |
| | | | | | | | | | | Cost of | | | Fair | |
| Portfolio Company (1)(3) | | Sector | | Type of Investment (7) | | Number of Shares | | | Investments (6)(9) | | | Value (9) | |
| Non-Controlled Affiliate Other Investments — 0.5% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12)(15) | | Biotechnology | | Other Investment | | | | | | | 20,092 | | | | 1,486 | |
| Total Non-Controlled Affiliate Other Investments | | | | | | | 20,092 | | | | 1,486 | |
| Non-controlled Affiliate Equity — 7.7% (8) | | | | | | | | | | | | | | | | |
| Aulea Medical, Inc. (12) | | Medical Device | | Common Stock | | | 660,537 | | | | — | | | | — | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock | | | 2,164,502 | | | | 5,000 | | | | — | |
| Hound Labs II, LLC (12) | | Diagnostics | | Preferred Stock | | | 4,769 | | | | 4,764 | | | | 4,764 | |
| NextCar Holding Company, Inc. (2)(12) | | Consumer-related Technologies | | Preferred Stock | | | 2,688,971 | | | | — | | | | — | |
| Nexii, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 168,377 | | | | 9,751 | | | | — | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Common Stock | | | 4,274,555 | | | | 1,292 | | | | 1,292 | |
| Shengrow, Inc. aka Soli Organic, Inc. (2)(12) | | Other Sustainability | | Preferred Stock | | | 1,964,733 | | | | 13,209 | | | | 18,355 | |
| Total Non-Controlled Affiliate Equity | | | | | | | 34,016 | | | | 24,411 | |
| Non-controlled Affiliate Warrants — 0.0% (8) | | | | | | | | | | | | | | | | |
| Evelo Holdings, Inc. (2)(5)(12) | | Biotechnology | | Common Stock Warrant | | | 23,196 | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Warrants | | | | | | | 127 | | | | — | |
| Total Non-Controlled Affiliate Portfolio Investment Assets | | | | | | | | | | $ | 89,033 | | | $ | 63,144 | |
| Total Portfolio Investment Assets — 203.2% (8) | | | | | | | | | | $ | 705,269 | | | $ | 647,244 | |
| Short Term Investments - Unrestricted Investments - 8.1% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 34,711 | | | | 34,711 | |
| Total Short Term Investments - Unrestricted Investments | | | $34,711 | | | | $34,711 | |
| | | | | | | | | |
| Short Term Investments - Restricted Investments - 1.0% (8) | | | | | | | | |
| US Bank Money Market Deposit Account | | | 2,463 | | | | 2,463 | |
| Total Short Term Investments - Restricted Investments | | | $2,463 | | | | $2,463 | |
|